» Authors » P Zak

P Zak

Explore the profile of P Zak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 89
Citations 251
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sokolova T, Paterova P, Zavrelova A, Visek B, Zak P, Radocha J
J Hosp Infect . 2024 Sep; 153:73-80. PMID: 39277087
Background: Febrile neutropenia (FN) is a common complication of stem cell transplantation. Aim: To evaluate the frequency of sepsis in patients with FN colonized with resistant Gram-negative bacteria (extended-spectrum β-lactamase...
2.
Chovanec V, Drugda J, Lojik M, Vodarek P, Zak P, Hanke I, et al.
Rozhl Chir . 2023 Feb; 101(12):607-611. PMID: 36759208
The authors present a case of a patient with non-traumatic right-sided chylothorax which was successfully treated by thoracic duct embolization. The procedure was performed through the cisterna chyli which was...
3.
Zak P, Bolt M, Pietraszuk C
RSC Adv . 2022 May; 8(70):40016-40021. PMID: 35558240
Platinum-N-heterocyclic carbene complex with the formula [Pt(IPr*)(dvtms)] (where IPr* = 1,3-bis{2,6-bis(diphenylmethyl)-4-methoxyphenyl}imidazol-2-ylidene, dvtms = divinyltetramethyldisiloxane) exhibits a high catalytic activity towards the β--selective hydrosilylation of terminal acetylenes with many secondary silanes...
4.
Belohlavkova P, Vrbacky F, Smolej L, Radocha J, Lanska M, Visek B, et al.
Leuk Res Rep . 2021 Nov; 16:100274. PMID: 34760617
In the present study, we retrospectively analysed the results of HSCT in 47 consecutive patients with MDS diagnosed at our department between 2002 and 2019, with a focus on possible...
5.
Horacek J, Kupsa T, Vanek J, Jakl M, Stajer M, Jebavy L, et al.
Exp Oncol . 2021 Sep; 43(3):234-236. PMID: 34591424
Aim: To evaluate serum levels of selected cytokine receptors in B-cell precursor acute lymphoblastic leukemia (B-ALL) and their association with acknowledged prognostic factors, relapse-free survival (RFS) and overall survival (OS)....
6.
cernan M, Szotkowski T, Hisemova M, Cetkovsky P, Sramkova L, Stary J, et al.
Neoplasma . 2020 Feb; 67(3):650-659. PMID: 32064883
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with aggressive behavior and poor prognosis. We present the first retrospective analysis mapping its incidence and therapeutic outcomes in...
7.
Vejrazkova E, Hubacek P, Pliskova L, Kostal M, Zavrelova A, Stepanova V, et al.
Epidemiol Mikrobiol Imunol . 2019 Aug; 68(2):71-74. PMID: 31398979
Introduction: The optimal dosage of anti-thymocyte globulin (ATG) may influence the outcome of patients after allogenic haematopoietic stem cell transplantation (HSCT). The aim of our study was to analyse human...
8.
Zak P, Vejrazkova E, Zavrelova A, Pliskova L, Ryskova L, Hubacek P, et al.
Folia Microbiol (Praha) . 2019 May; 65(1):109-120. PMID: 31073843
The present study aims to evaluate the diagnostic yield of bronchoalveolar lavage (BAL) fluid in patients with hematological malignancies and describe the most common pathogens detected in BAL fluid (BALF.)...
9.
Zak P, Soucek M
Physiol Res . 2019 Mar; 68(3):395-408. PMID: 30904009
Several pathophysiological mechanisms have been proposed in the development of pregnancy complications, including endothelial dysfunction, an inflammatory pathway and oxidative stress. The aim of the present study was to evaluate...
10.
Kralickova P, Kuhnova J, Soucek O, Vodarek P, Zak P, Simkovic M, et al.
J Immunol Res . 2018 Feb; 2017:7304658. PMID: 29392143
Humoral deficiencies represent a broad group of disorders. The aim of the study was to compare the levels of antibodies against pneumococcal capsular polysaccharides (anti-PCP) and natural anti-galactosyl (anti-Gal) antibodies...